Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: March 04, 2022
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis.
Journal: Alimentary pharmacology & therapeutics
Published: October 08, 2021
Showing 1-2 of 2
Last Updated: 09/26/2026